Ortho Evra Patch

Ortho Evra Patch Litigation at The Lanier Law Firm

The Ortho Evra Patch (Norlegstromin/ethinyl estradiol) is an adhesive, transdermal birth control patch manufactured by Ortho-McNeil, a division of Johnson & Johnson. It was approved by the U.S. Food and Drug Administration in November 2001. Unlike the birth control pill, which is ingested and metabolized by the body's digestive system, the medication in Ortho Evra is released directly into the bloodstream. Since its launch, more than 4 million women have used the Ortho Evra Patch.

In November 2005, the FDA approved an updated label for Ortho Evra to warn healthcare providers and patients that the patch exposed women to higher levels of estrogen than most birth control pills. Increased estrogen exposure has been known to increase the risk of blood clots. According to the FDA's press release, the revised warning was the result of the FDA's and Ortho-McNeil's analysis, directly comparing the levels for estrogen and progestin hormones in users of Ortho Evra with those in a typical birth control pill.

Based on recent reports and research, Ortho Evra is believed to be associated with heart attacks, strokes and pulmonary embolism, caused by blood clotting. It is alleged that Ortho-McNeil was aware of the increased medical risks associated with Ortho Evra before the drug was approved and that, once approved, the company failed to adequately warn patients about these risks.

If you or a loved one has used the Ortho Evra Patch and suffered side effects, please contact our office for a free evaluation.

Ortho Evra Patch Information Links:

2005 FDA Ortho Evra Patch News Release

2005 FDA Ortho Evra Patch Patient Information Sheet

2005 FDA Ortho Evra Patch Questions and Answers

"Birth Control Patch Users Warned", CBS News: The Early Show (November 11, 2005)

PDF
Print
bp-oil-spill-faq
Oil Spill Lawsuit

Law Firm News

Email Spam Patent Lawsuit Filed

The Lanier Law Firm filed a patent-infringement lawsuit against 36 companies including Apple and Google.


Lanier Named One of "The 25 Greatest Texas Lawyers"

Texas Lawyer selected W. Mark Lanier as one of the 25 greatest Texas lawyers of the past quarter-century.


BP Investigation - UPDATE

Many employees of BP may face huge retirement losses. Our team investigates.


Oil Spill Lawsuit - UPDATE

The Lanier Law Firm announced a class action lawsuit filed on behalf of people affected by the Gulf oil spill.


Decade's Most Influential Lawyers

Mark Lanier named one of "The Decade's Most Influential Lawyers" by editors of The National Law Journal.


Toyota Lawsuit

Mark Lanier discusses the Toyota lawsuit with Neil Cavuto on FOX News.


Pacemaker Lawsuit Successfully Resolved

The Lanier Law Firm settled a patent-infringement lawsuit against St. Jude Medical.


International Arbitration and Disputes

The Lanier Law Firm handles international arbitration and disputes for corporations.


Levaquin Side Effects
The antibiotic Levaquin is being targeted for causing irreparable injuries to patients.

Offices

Houston Law Office
713-659-5200 main
800-723-3216 toll free
713-659-2204 fax

New York Law Office
212-421-2800 main
800-723-3216 toll free
212-421-2878 fax

Los Angeles Law Office
800-723-3216 toll free
713-659-2204 fax

Palo Alto Law Office
650-322-9100 main
800-723-3216 toll free
650-322-9103 fax
Law Firm Locations: Houston Law Firm | New York Law Firm | Los Angeles Law Firm | Palo Alto Law Firm
© 2008 The Lanier Law Firm. All rights reserved. Disclaimer: Client's rights and responsibilities.
Past results do not guarantee similar outcomes in future cases.
Contact The Lanier Law Firm for more information.
Attorney Advertising